Visualize the competitive landscape across development phases, mechanisms of action (MoA), and routes of administration.
Track clinical trial activity, including start dates, enrolment targets, patient segments, and geographic distribution.
Track licensing and M&A activity, including deal values, milestones, and strategic partnerships.
Assess commercial potential using metrics like peak sales, net present value (NPV), and probability of technical and regulatory success (PS-PTRS).
Access abstracts, posters, and analyst commentary from key industry conferences.
Access predicted FDA approval dates and probability of technical and regulatory success (PS-PTRS) for assets.
Explore historical and forecasted sales at the indication level, with visualizations of market share and growth trends.
Surface key market-moving events (e.g., trial readouts, regulatory filings, partnerships) with analyst commentary.
Aggregates and categorizes news by company, product, and update type, with links to deeper analysis.
Transform how your CI is gathered and shared with automated presentation-ready deliverables including pipeline landscapes, trial timelines, and approval forecasts. Enable your team to focus on strategy, not spreadsheets with instantly accessible, and real-time data from Norstella’s gold-standard sources.
Enable CI leaders and cross-functional teams to focus on what matters by centralizing your intelligence across multiple therapeutic areas and custom dashboards. Built-in collaboration tools and the ability to overlay business-specific insights ensure alignment from analysts to executives.
Say goodbye to fragmented tools and costly vendor reports, with access to integrated data from eight trusted sources into one platform. Advanced filtering, customizable alerts, and seamless export options streamline workflows, reduce spend, and boost internal engagement.
Evaluate’s CI practice delivers more than data. As your CI needs evolve, our consulting team adapts to provide the coverage, analysis and strategic insights tailored to your goals.
With deep domain expertise, our consultants provide everything from continuous monitoring of your space to deep dives, conference coverage, and strategic workshops our consultants can answer bespoke questions.
As a neuroscientist, consultant and commercial leader, Kelly brings more than 16 years of experience in the life sciences sector. She partners with insights, analytics, and commercial strategy teams to transform how pharmaceutical organizations capture and operationalize market intelligence. At Evaluate, Kelly focuses on creative solutioning, bringing together life science consultants, data scientists, and subject‑matter experts to build custom intelligence programs and products that leverage the full breadth of Norstella’s assets, including gold-standard forecasting, real‑world data, market access insights, and expert journalistic intelligence. With expertise in competitive landscape analysis, tech-enabled secondary monitoring, primary research, and comprehensive conference coverage, her work supports translation of complex market signals into clear, actionable insights. Kelly holds a PhD in Neuroscience from Georgetown University and completed a postdoctoral fellowship at the National Institute of Neurological Disorders and Stroke (NINDS).
Get in touch with our team to explore the right solutions for your business.
